MedPAC examines Medicare quality measurement, drug spending
At meetings this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data. Commissioners also received a status report on Medicare Accountable Care Organizations. The commission will meet again in November.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services will host its seventh annual CMS & Health Level Seven International Fast Healthcare Interoperability…
Headline
A Centers for Disease Control and Prevention report published April 7 found that 47.2% of all U.S. adults met federal guidelines for aerobic physical activity…
Headline
The AHA’s American Society for Health Care Engineering announced April 7 that registration has opened for the 2026 Health Care Facilities Innovation Conference…
Headline
The Centers for Medicare & Medicaid Services April 6 released the Medicare Advantage and Part D Rate Announcement for calendar year 2027. The rate…
Headline
The U.S. District Court for the District of Columbia March 31 vacated a Health Resources and Services Administration policy instituted in 2013 that restricted…
Headline
The role of the chief medical officer is rapidly evolving as health care systems focus on the present and future. In this conversation, Phillip Chang, M.D.,…